Management

Andreas Treml helms and oversees business operations, As co-founder of Origenis he is represents biological expertise to the management team.  In prior positions he was responsible for assay development and integrating ‘New Technologies’ for parallel biological characterization. Andreas holds a Ph.D. in biology and worked in the field of steroid hormone receptors and transcription factors for therapeutic oncology and across multiple therapeutic target areas during industrial and academic collaborations.